(Q40626774)

22 September 2017

title

Estimated risk of transfusion-transmitted viral infections in Spain (English)

1 reference

22 September 2017

Manuel Alvarez

1

1 reference

22 September 2017

Salvador Oyonarte

series ordinal

2

1 reference

22 September 2017

P M Rodríguez

series ordinal

3

1 reference

22 September 2017

J M Hernández

series ordinal

4

1 reference

22 September 2017

publication date

1 August 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

42

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

994-998

1 reference

[Residual risks of viral transmission by transfusions and projected yields of additional screening tests. Retrovirus Epidemiology Donors Study (REDS)].

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

[Estimation of risk of virus transmission in hepatitis B and C and human retrovirus via transfusion of labile blood derivatives].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

Efficacy of HCV core antigen detection during the preseroconversion period

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00154.X

10.1046/J.1537-2995.2002.00154.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference